<DOC>
	<DOCNO>NCT01078220</DOCNO>
	<brief_summary>This post-licensure safety surveillance program detect potential safety signal subject , manage care organization database , use GARDASIL™ .</brief_summary>
	<brief_title>Observational Surveillance Study Detect Potential Safety Signals Patients Who Have Had Least One Dose GARDASIL™ ( V501-031 )</brief_title>
	<detailed_description />
	<mesh_term>Papillomavirus Infections</mesh_term>
	<criteria>3Dose Safety Population Female 926 year time first dose GARDASIL™ Completed 3dose regimen GARDASIL™ per protocol Pregnancy Safety Population Received least one dose GARDASIL™ 30 day prior date conception time conception day pregnancy resolution Autoimmune Safety Population Female receive least one dose GARDASIL™ Has member Managed Care Organization ( MCO ) least 12 month prior receipt GARDASIL™ Any Dose Safety Population Female receive least one dose GARDASIL™ 3Dose Safety Population Male Receives incomplete regimen GARDASIL™ Completes three dose regimen GARDASIL™ 12 month Less 28 day interval dose 1 2 less 12 week interval dose 2 3 Younger 9 old 26 year age receipt first dose Pregnancy Safety Population Males No record pregnancy Managed Care Organization ( MCO ) Autoimmune Safety Population Member MCO le 12 month prior receive first dose Male</criteria>
	<gender>Female</gender>
	<minimum_age>9 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2015</verification_date>
	<keyword>Human Papillomavirus ( HPV )</keyword>
</DOC>